FDA Import Refusal SCS-4248193-9/11/11 — Hikma Pharmaceuticals USA INC.

Hikma Pharmaceuticals USA INC. — FEI 1510690

The FDA refused shipment SCS-4248193-9/11/11 from Hikma Pharmaceuticals USA INC. (United States) on Mar 2, 2021. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Mar 2, 2021
Country
United States
Product Category
Drugs and Biologics
Product Code
61PDA66 LINAGLIPTIN (ANTI-DIABETIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.